A Large-Scale Genome-Wide Gene-Gene Interaction Study of Lung Cancer Susceptibility in Europeans With a Trans-Ethnic Validation in Asians
暂无分享,去创建一个
L. Kiemeney | Hongbing Shen | A. Tardón | S. Shete | G. Rennert | Yuzhuo Wang | C. Amos | L. Le Marchand | Zhibin Hu | S. Bojesen | A. Andrew | M. Schabath | A. Risch | H. Bickeböller | M. Aldrich | M. Johansson | Geoffrey Liu | R. Hung | Yang Zhao | Ruyang Zhang | J. Dai | Hongxia Ma | Yongyue Wei | P. Brennan | M. Landi | N. Caporaso | H. Wichmann | Xiangjun Xiao | J. Field | Yafang Li | P. Lazarus | Dakai Zhu | Chu Chen | Meng Zhu | Angie M. Cox | D. Christiani | S. Shen | Susanne M. Arnold | James Mckay | Jiajin Chen | Feng Chen | A. Behndig | D. Albanes | Mikael Johansson | J. Guan | Yi Li | Junxing Xie | S. Lam | Shan Zienolddiny-Narui | Ying Zhu | Yi Li | Zoucheng Pan | M. Zhu | J. Mckay | S. Arnold | Hongxia Ma
[1] Hongbing Shen,et al. A multi-omics study links TNS3 and SEPT7 to long-term former smoking NSCLC survival , 2021, npj Precision Oncology.
[2] P. Collins,et al. Discrimination of single-point mutations in unamplified genomic DNA via Cas9 immobilized on a graphene field-effect transistor , 2021, Nature Biomedical Engineering.
[3] M. Cabana,et al. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. , 2021, JAMA.
[4] Xiaopei Shen,et al. Therapeutic targeting of FOS in mutant TERT cancers through removing TERT suppression of apoptosis via regulating survivin and TRAIL-R2 , 2021, Proceedings of the National Academy of Sciences.
[5] Daniel J. Gaffney,et al. Genome-wide meta-analysis, fine-mapping, and integrative prioritization implicate new Alzheimer’s disease risk genes , 2021, Nature Genetics.
[6] L. Kiemeney,et al. Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model , 2021, Cancer Research.
[7] A. Jemal,et al. Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.
[8] S. Duffy,et al. Liverpool Lung Project lung cancer risk stratification model: calibration and prospective validation , 2020, Thorax.
[9] M. Oudkerk,et al. Lung cancer LDCT screening and mortality reduction — evidence, pitfalls and future perspectives , 2020, Nature Reviews Clinical Oncology.
[10] Shing Wan Choi,et al. Tutorial: a guide to performing polygenic risk score analyses , 2020, Nature Protocols.
[11] S. A. Lambert,et al. The Polygenic Score Catalog: an open database for reproducibility and systematic evaluation , 2020, medRxiv.
[12] E. Guallar,et al. Chronic obstructive pulmonary disease and lung cancer incidence in never smokers: a cohort study , 2020, Thorax.
[13] M. Esteller,et al. Independent Validation of Early-Stage Non-Small Cell Lung Cancer Prognostic Scores Incorporating Epigenetic and Transcriptional Biomarkers With Gene-Gene Interactions and Main Effects , 2020, Chest.
[14] Harry J de Koning,et al. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. , 2020, The New England journal of medicine.
[15] M. He,et al. Daily cooking duration and its joint effects with genetic polymorphisms on lung cancer incidence: Results from a Chinese prospective cohort study. , 2019, Environmental research.
[16] Hongbing Shen,et al. Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations. , 2019, The Lancet. Respiratory medicine.
[17] K. Fong,et al. Chronic obstructive pulmonary disease (COPD) and lung cancer: common pathways for pathogenesis. , 2019, Journal of thoracic disease.
[18] Z. Ling,et al. Deregulation of CSMD1 targeted by microRNA-10b drives gastric cancer progression through the NF-κB pathway , 2019, International journal of biological sciences.
[19] H. Morgenstern,et al. Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region. , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[20] L. Kiemeney,et al. Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity , 2018, Nature Communications.
[21] L. Wain,et al. Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk , 2018, Nature Communications.
[22] V. Bansal,et al. Genome-wide association study results for educational attainment aid in identifying genetic heterogeneity of schizophrenia , 2018, Nature Communications.
[23] Selecting lung cancer screenees using risk prediction models-where do we go from here. , 2018, Translational lung cancer research.
[24] P. Mazzone,et al. Screening for Lung Cancer: CHEST Guideline and Expert Panel Report , 2018, Chest.
[25] Calliope A. Dendrou,et al. HLA variation and disease , 2018, Nature Reviews Immunology.
[26] Witold Rzyman,et al. European position statement on lung cancer screening. , 2017, The Lancet. Oncology.
[27] Lars G Fritsche,et al. Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies , 2017, Nature Genetics.
[28] Y. Bossé,et al. A Decade of GWAS Results in Lung Cancer , 2017, Cancer Epidemiology, Biomarkers & Prevention.
[29] William S. Bush,et al. Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes , 2017, Nature Genetics.
[30] Jiawei Shen,et al. Genome‐wide two‐locus interaction analysis identifies multiple epistatic SNP pairs that confer risk of prostate cancer: A cross‐population study , 2017, International journal of cancer.
[31] Seunggeun Lee,et al. A fast and accurate algorithm to test for binary phenotypes and its application to PheWAS , 2017, bioRxiv.
[32] Tangchun Wu,et al. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer , 2016, Cancer Gene Therapy.
[33] Dennis J. Hazelett,et al. The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers , 2016, Cancer Epidemiology, Biomarkers & Prevention.
[34] N. Eriksson,et al. Genome-wide analysis identifies 12 loci influencing human reproductive behavior , 2016 .
[35] Krista A. Zanetti,et al. Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population. , 2016, Lung cancer.
[36] Shane A. McCarthy,et al. Reference-based phasing using the Haplotype Reference Consortium panel , 2016, Nature Genetics.
[37] C. la Vecchia,et al. Risk factors for lung cancer worldwide , 2016, European Respiratory Journal.
[38] G. Parmigiani,et al. Familial Risk and Heritability of Cancer Among Twins in Nordic Countries. , 2016, JAMA.
[39] Xihong Lin,et al. Genome-wide Gene–Asbestos Exposure Interaction Association Study Identifies a Common Susceptibility Variant on 22q13.31 Associated with Lung Cancer Risk , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[40] G. Kempermann. Faculty Opinions recommendation of Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. , 2015 .
[41] M. Resh,et al. Hedgehog Acyltransferase as a target in estrogen receptor positive, HER2 amplified, and tamoxifen resistant breast cancer cells , 2015, Molecular Cancer.
[42] P. Elliott,et al. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.
[43] P. Brennan,et al. Effect of Occupational Exposures on Lung Cancer Susceptibility: A Study of Gene–Environment Interaction Analysis , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[44] Jian Huang,et al. Group descent algorithms for nonconvex penalized linear and logistic regression models with grouped predictors , 2012, Statistics and Computing.
[45] G. Beatty,et al. Immune Escape Mechanisms as a Guide for Cancer Immunotherapy , 2014, Clinical Cancer Research.
[46] Tyler J. VanderWeele,et al. A Tutorial on Interaction , 2014 .
[47] K. Straif,et al. Is previous respiratory disease a risk factor for lung cancer? , 2014, American journal of respiratory and critical care medicine.
[48] Hongbing Shen,et al. A genome-wide gene-environment interaction analysis for tobacco smoke and lung cancer susceptibility. , 2014, Carcinogenesis.
[49] William Wheeler,et al. Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer , 2014, Nature Genetics.
[50] Julian Peto,et al. A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium. , 2014, Human molecular genetics.
[51] Yang Zhao,et al. A genome-wide gene-gene interaction analysis identifies an epistatic gene pair for lung cancer susceptibility in Han Chinese. , 2014, Carcinogenesis.
[52] M. You,et al. Crr9/clptm1l Regulates Cell Survival Signaling and Is Required for Ras Transformation and Lung Tumorigenesis Figures: 7 Main Text and 7 Supplementary , 2022 .
[53] Kai-Ping Chang,et al. How Genome-Wide SNP-SNP Interactions Relate to Nasopharyngeal Carcinoma Susceptibility , 2013, PloS one.
[54] C. Carlson,et al. Genome-Wide Search for Gene-Gene Interactions in Colorectal Cancer , 2012, PloS one.
[55] B. Qian,et al. Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia , 2012, Nature Genetics.
[56] Eurie L. Hong,et al. Annotation of functional variation in personal genomes using RegulomeDB , 2012, Genome research.
[57] Yang Zhao,et al. Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls , 2012, Human molecular genetics.
[58] Attila Gyenesei,et al. BiForce Toolbox: powerful high-throughput computational analysis of gene–gene interactions in genome-wide association studies , 2012, Nucleic Acids Res..
[59] Guangchuang Yu,et al. clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.
[60] Jianfeng Xu,et al. Genome-wide two-locus epistasis scans in prostate cancer using two European populations , 2012, Human Genetics.
[61] E. Lander,et al. The mystery of missing heritability: Genetic interactions create phantom heritability , 2012, Proceedings of the National Academy of Sciences.
[62] Manolis Kellis,et al. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..
[63] M. Spitz,et al. Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk. , 2011, Carcinogenesis.
[64] W. Willett,et al. Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study. , 2011, Cancer research.
[65] A. Ashworth,et al. Genetic Interactions in Cancer Progression and Treatment , 2011, Cell.
[66] Judy H. Cho,et al. Finding the missing heritability of complex diseases , 2009, Nature.
[67] R. Houlston,et al. The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung. , 2009, Carcinogenesis.
[68] Jack A. Taylor,et al. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies , 2009, Nucleic Acids Res..
[69] Simon Heath,et al. Lung cancer susceptibility locus at 5p15.33 , 2008, Nature Genetics.
[70] Joshua M. Korn,et al. Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs , 2008, Nature Genetics.
[71] W. Bodmer,et al. Common and rare variants in multifactorial susceptibility to common diseases , 2008, Nature Genetics.
[72] Jichun Chen,et al. Telomerase: not just for the elongation of telomeres. , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.
[73] J. Luketich,et al. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[74] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[75] L. Ger,et al. [Risk factors of lung cancer]. , 1992, Journal of the Formosan Medical Association = Taiwan yi zhi.